Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · Real-Time Price · USD

9.32

-0.78 (-7.72%)

At close: May 29, 2026, 4:00 PM EDT

9.95

+0.63 (6.76%)

After-hours: May 29, 2026, 7:08 PM EDT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharma Research and Development Channel	155.54M	115.68M	115.92M	73.17M	23.39M
Pharma Research and Development Channel Growth	34.46%	-0.21%	58.42%	212.79%	59.26%
In-Hospital Channel	224.04M	224.49M	188.70M	175.30M	165.12M
In-Hospital Channel Growth	-0.20%	18.97%	7.65%	6.17%	40.08%
Central Laboratory Channel	159.99M	175.65M	232.81M	314.77M	319.35M
Central Laboratory Channel Growth	-8.91%	-24.55%	-26.04%	-1.44%	7.40%
Total	539.57M	515.82M	537.44M	563.24M	507.86M
Total Growth	4.60%	-4.02%	-4.58%	10.90%	18.13%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Overseas	100.93M	100.09M	61.24M	-	-
Overseas Growth	0.84%	63.42%	-	-	-
Mainland China	438.64M	415.73M	476.19M	-	-
Mainland China Growth	5.51%	-12.70%	-	-	-
People’s Republic of China (PRC)	-	-	-	553.30M	504.05M
People’s Republic of China (PRC) Growth	-	-	-	9.77%	17.25%
United States	-	-	-	9.93M	3.81M
United States Growth	-	-	-	160.73%	-
Total	539.57M	515.82M	537.44M	563.24M	507.86M
Total Growth	4.60%	-4.02%	-4.58%	10.90%	18.13%

Source: S&P Global Market Intelligence.